Management of Massive Pulmonary Embolism

Management of Massive Pulmonary Embolism

Pulmonary embolism is a potentially lethal manifestation of venous thromboembolic disease. It is one of the three main causes of cardiovascular morbidity and mortality in developed countries. Over the years, better diagnostic and risk stratification measures were implemented. A generous range of new...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The International journal of angiology 2022-09, Vol.31 (3), p.194-197
Hauptverfasser: Polaková, Eva, Veselka, Josef
Format: Artikel
Sprache:eng
Schlagworte:
Invited
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 197
container_issue 3
container_start_page 194
container_title The International journal of angiology
container_volume 31
creator Polaková, Eva
Veselka, Josef
description Pulmonary embolism is a potentially lethal manifestation of venous thromboembolic disease. It is one of the three main causes of cardiovascular morbidity and mortality in developed countries. Over the years, better diagnostic and risk stratification measures were implemented. A generous range of new treatment options is becoming available, particularly for management of massive pulmonary embolism. Nonetheless, clinicians often face uncertainty in clinical practice due to lack of scientific support for available treatment options. The aim of this article is to review management of massive pulmonary embolism.
doi_str_mv 10.1055/s-0042-1756176
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9507601</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2718638520</sourcerecordid><originalsourceid>FETCH-LOGICAL-c327t-8f1217b863cf1f38e162ea494c91b2a4c67de67f13afa2efcc22ab46c06c460a3</originalsourceid><addsrcrecordid>eNpVkM1LAzEUxIMotlavnvfYy9a8ZJPsXgQp9QNa9KDn8DZN6spmUzfdgv-9KS2CpzcwP-YNQ8gt0BlQIe5iTmnBclBCgpJnZAwSRC4qXp0nTSUkC2BErmL8ohSUkuKSjHiCFK3UmExX2OHGetvtsuCyFcbY7G32NrQ-dNj_ZAtfh7aJ_ppcOGyjvTndCfl4XLzPn_Pl69PL_GGZG87ULi8dMFB1Kblx4HhpQTKLRVWYCmqGhZFqbaVywNEhs84YxrAupKHSFJIin5D7Y-52qL1dm1Ssx1Zv-8anOjpgo_87XfOpN2GvK0GVpJACpqeAPnwPNu60b6KxbYudDUPUTEFqVwpGEzo7oqYPMfbW_b0Bqg_z6qgP8-rTvPwXdzVr4Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2718638520</pqid></control><display><type>article</type><title>Management of Massive Pulmonary Embolism</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Polaková, Eva ; Veselka, Josef</creator><creatorcontrib>Polaková, Eva ; Veselka, Josef</creatorcontrib><description>Pulmonary embolism is a potentially lethal manifestation of venous thromboembolic disease. It is one of the three main causes of cardiovascular morbidity and mortality in developed countries. Over the years, better diagnostic and risk stratification measures were implemented. A generous range of new treatment options is becoming available, particularly for management of massive pulmonary embolism. Nonetheless, clinicians often face uncertainty in clinical practice due to lack of scientific support for available treatment options. The aim of this article is to review management of massive pulmonary embolism.</description><identifier>ISSN: 1061-1711</identifier><identifier>EISSN: 1615-5939</identifier><identifier>DOI: 10.1055/s-0042-1756176</identifier><identifier>PMID: 36157097</identifier><language>eng</language><publisher>333 Seventh Avenue, 18th Floor, New York, NY 10001, USA: Thieme Medical Publishers, Inc</publisher><subject>Invited</subject><ispartof>The International journal of angiology, 2022-09, Vol.31 (3), p.194-197</ispartof><rights>International College of Angiology. This article is published by Thieme. 2022 International College of Angiology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c327t-8f1217b863cf1f38e162ea494c91b2a4c67de67f13afa2efcc22ab46c06c460a3</citedby><cites>FETCH-LOGICAL-c327t-8f1217b863cf1f38e162ea494c91b2a4c67de67f13afa2efcc22ab46c06c460a3</cites><orcidid>0000-0002-9158-3883</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9507601/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9507601/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids></links><search><creatorcontrib>Polaková, Eva</creatorcontrib><creatorcontrib>Veselka, Josef</creatorcontrib><title>Management of Massive Pulmonary Embolism</title><title>The International journal of angiology</title><description>Pulmonary embolism is a potentially lethal manifestation of venous thromboembolic disease. It is one of the three main causes of cardiovascular morbidity and mortality in developed countries. Over the years, better diagnostic and risk stratification measures were implemented. A generous range of new treatment options is becoming available, particularly for management of massive pulmonary embolism. Nonetheless, clinicians often face uncertainty in clinical practice due to lack of scientific support for available treatment options. The aim of this article is to review management of massive pulmonary embolism.</description><subject>Invited</subject><issn>1061-1711</issn><issn>1615-5939</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpVkM1LAzEUxIMotlavnvfYy9a8ZJPsXgQp9QNa9KDn8DZN6spmUzfdgv-9KS2CpzcwP-YNQ8gt0BlQIe5iTmnBclBCgpJnZAwSRC4qXp0nTSUkC2BErmL8ohSUkuKSjHiCFK3UmExX2OHGetvtsuCyFcbY7G32NrQ-dNj_ZAtfh7aJ_ppcOGyjvTndCfl4XLzPn_Pl69PL_GGZG87ULi8dMFB1Kblx4HhpQTKLRVWYCmqGhZFqbaVywNEhs84YxrAupKHSFJIin5D7Y-52qL1dm1Ssx1Zv-8anOjpgo_87XfOpN2GvK0GVpJACpqeAPnwPNu60b6KxbYudDUPUTEFqVwpGEzo7oqYPMfbW_b0Bqg_z6qgP8-rTvPwXdzVr4Q</recordid><startdate>20220901</startdate><enddate>20220901</enddate><creator>Polaková, Eva</creator><creator>Veselka, Josef</creator><general>Thieme Medical Publishers, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9158-3883</orcidid></search><sort><creationdate>20220901</creationdate><title>Management of Massive Pulmonary Embolism</title><author>Polaková, Eva ; Veselka, Josef</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c327t-8f1217b863cf1f38e162ea494c91b2a4c67de67f13afa2efcc22ab46c06c460a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Invited</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Polaková, Eva</creatorcontrib><creatorcontrib>Veselka, Josef</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The International journal of angiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Polaková, Eva</au><au>Veselka, Josef</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management of Massive Pulmonary Embolism</atitle><jtitle>The International journal of angiology</jtitle><date>2022-09-01</date><risdate>2022</risdate><volume>31</volume><issue>3</issue><spage>194</spage><epage>197</epage><pages>194-197</pages><issn>1061-1711</issn><eissn>1615-5939</eissn><abstract>Pulmonary embolism is a potentially lethal manifestation of venous thromboembolic disease. It is one of the three main causes of cardiovascular morbidity and mortality in developed countries. Over the years, better diagnostic and risk stratification measures were implemented. A generous range of new treatment options is becoming available, particularly for management of massive pulmonary embolism. Nonetheless, clinicians often face uncertainty in clinical practice due to lack of scientific support for available treatment options. The aim of this article is to review management of massive pulmonary embolism.</abstract><cop>333 Seventh Avenue, 18th Floor, New York, NY 10001, USA</cop><pub>Thieme Medical Publishers, Inc</pub><pmid>36157097</pmid><doi>10.1055/s-0042-1756176</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-9158-3883</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1061-1711
ispartof The International journal of angiology, 2022-09, Vol.31 (3), p.194-197
issn 1061-1711
1615-5939
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9507601
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Invited
title Management of Massive Pulmonary Embolism
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T16%3A00%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20of%20Massive%20Pulmonary%20Embolism&rft.jtitle=The%20International%20journal%20of%20angiology&rft.au=Polakov%C3%A1,%20Eva&rft.date=2022-09-01&rft.volume=31&rft.issue=3&rft.spage=194&rft.epage=197&rft.pages=194-197&rft.issn=1061-1711&rft.eissn=1615-5939&rft_id=info:doi/10.1055/s-0042-1756176&rft_dat=%3Cproquest_pubme%3E2718638520%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2718638520&rft_id=info:pmid/36157097&rfr_iscdi=true